Bringing the fundamentals into focus…
Back to Quest Diagnostics Incorporated
How Quest Diagnostics Incorporated stacks up
DGX · against 89 other Healthcare companies of similar size
Valuation
66/ 100
Above the middle of the pack.
Ranked #28 of 90 · scores higher than 70% of peers
Bars: peers in each 10-point band of the valuation score19 peers with a valuation score of 60–69, including DGX · Click a bar to see the companies
Why valuation scores 66?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
- more operating profit (EBITDA) for the company's total value: stronger than 66% of peers. EBITDA yield: 6.9% vs peer median 4.0%
- higher earnings for the price paid: stronger than 69% of peers. Earnings yield: 3.9% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 78% of peers. Free cash flow yield: 4.9% vs peer median 0.0%
Metric by metric
Position: dot = DGX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DGX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 87 reported | 3.8% | 2.8% | 67% | 30% | |
| EBITDA yieldHigher is better · 90 reported | 6.8% | 5.2% | 72% | 50% | |
| Free cash flow yieldHigher is better · 59 reported | 4.9% | 3.6% | 74% | 20% | |
| Book yieldHigher is better · 83 reported | 27.7% | 20.1% | 62% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around DGX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 3 | 14.4B USD | 92 | 71 | |
| 4 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 5 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 24 | 13.9B EUR (≈$15.3B) | 68 | 78 | |
| 24 | 32.8B USD | 68 | 69 | |
| 26 | 17.9B USD | 67 | 76 | |
| 26 | 133.4B BRL (≈$24.0B) | 67 | 49 | |
| 28 | 27.3B USD | 66 | 55 | |
| 29 | 177.2B HKD (≈$22.7B) | 65 | 73 | |
| 29 | 22.6B USD | 65 | 59 | |
| 31 | 225.2B CNY (≈$31.5B) | 64 | 63 | |
| 31 | 193.6B HKD (≈$24.8B) | 64 | 78 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score